Oncolytics Biotech Balance Sheet Health

Financial Health criteria checks 4/6

Oncolytics Biotech has a total shareholder equity of CA$9.1M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$24.3M and CA$15.2M respectively.

Key information

0%

Debt to equity ratio

CA$0

Debt

Interest coverage ration/a
CashCA$19.60m
EquityCA$9.06m
Total liabilitiesCA$15.21m
Total assetsCA$24.26m

Recent financial health updates

Recent updates

We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Feb 23
We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?

Nov 10
Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?

We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Jul 07
We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?

Mar 24
Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?

Is Oncolytics Biotech (TSE:ONC) In A Good Position To Invest In Growth?

Dec 09
Is Oncolytics Biotech (TSE:ONC) In A Good Position To Invest In Growth?

We're Keeping An Eye On Oncolytics Biotech's (TSE:ONC) Cash Burn Rate

Aug 25
We're Keeping An Eye On Oncolytics Biotech's (TSE:ONC) Cash Burn Rate

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

May 12
Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth

Dec 02
We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth

We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth

Aug 05
We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth

Companies Like Oncolytics Biotech (TSE:ONC) Are In A Position To Invest In Growth

Apr 15
Companies Like Oncolytics Biotech (TSE:ONC) Are In A Position To Invest In Growth

We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Dec 31
We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Financial Position Analysis

Short Term Liabilities: ONC's short term assets (CA$22.9M) exceed its short term liabilities (CA$7.7M).

Long Term Liabilities: ONC's short term assets (CA$22.9M) exceed its long term liabilities (CA$7.5M).


Debt to Equity History and Analysis

Debt Level: ONC is debt free.

Reducing Debt: ONC has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ONC has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ONC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 11.1% each year


Discover healthy companies